Clinical Trial Update: Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Nimotuzumab combined with neoadjuvant chemotherapy for resectable locally advanced head and neck squamous cell carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Xijing Hospital | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN